Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel.
The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.
Stienlauf
Shmuel
S
Sheba Medical Center, Tel Hashomer, Israel. sshmuel@netvision.net.il
Yahalom
Vered
V
Schwartz
Eli
E
Shinar
Eilat
E
Segal
Gad
G
Sidi
Yechezkel
Y
D000465:Algorithms; D001782:Blood Donors / Q000706:statistics & numerical data*; D004641:Emigration and Immigration / Q000706:statistics & numerical data; D005260:Female; D005843:Geography; D015481:HTLV-I Antibodies / Q000097:blood; D015490:HTLV-I Infections / Q000453:epidemiology* / Q000276:immunology; D015482:HTLV-II Antibodies / Q000097:blood; D006801:Humans; D007557:Israel / Q000453:epidemiology; D008297:Male; D008403:Mass Screening / Q000592:standards; D015995:Prevalence
D015481:HTLV-I Antibodies; D015482:HTLV-II Antibodies